KIR3DL1 and leukemia: Indeed, because of the half mismatch, some of the inhibitory KIR of the donor’s NK cells will not be engaged by the patient’s HLA class I molecules, and therefore, these donor’s NK cells will not be suppressed and can mediate graft versus leukemia [53].